Announcement under Regulation 30 (LODR)-Allotment
Filed with BSE · · 5 pages · English
Summary by 6ix AI
Venmax Drugs & Pharmaceuticals Ltd. has announced the conversion of warrants and the allotment of equity shares to several warrant holders. This allotment increases the company's paid-up capital significantly, reflecting the conversion of warrants into equity shares. The filing serves to inform the stock exchange and shareholders about this significant corporate action.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jul 14 2026
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jun 27 2026
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release May 06 2026
Later from Venmax Drugs & Pharmaceuticals
- Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Aug 01 2026
- Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Statement Of Deviation & Variation
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals